Medical Device FDA Insider Intelligence | Quarterly Report

$149.99

Stay informed about FDA enforcement trends affecting medical device manufacturers with ComplyFDA’s Quarterly Medical Device Insider Intelligence Report.

Explore FDA warning letters, frequently cited quality system deficiencies, QMSR and ISO 13485:2016 compliance concerns, design controls, CAPA, supplier oversight, and manufacturing quality trends.

Designed for Quality Assurance, Regulatory Affairs, Compliance, R&D, and Manufacturing professionals seeking actionable intelligence to support FDA inspection readiness, regulatory risk management, and quality system improvements.

Description

Medical Device FDA Insider Intelligence | Quarterly Regulatory Report

Stay ahead of FDA enforcement trends, identify recurring medical device compliance deficiencies, and strengthen inspection readiness with ComplyFDA’s quarterly regulatory intelligence.

FDA warning letters and regulatory citations reveal critical weaknesses in medical device quality management systems, manufacturing controls, design processes, and regulatory compliance. ComplyFDA’s Medical Device Insider Intelligence Report examines documented enforcement activity, citation patterns, and quality system deficiencies to help manufacturers anticipate regulatory scrutiny and prioritize corrective actions.

What’s Inside This Report?

  • FDA Enforcement Trends: Quarterly analysis of medical device regulatory citations, including cGMP, packaging, clinical activities, and historical enforcement comparisons.
  • Quality Management System Deficiencies: Examination of recurring quality system weaknesses involving documented procedures, production control records, validation, risk management, and quality controls.
  • FDA Quality Management System Regulation (QMSR): Analysis of cited ISO 13485:2016 requirements, including product realization, design and development controls, purchasing, process validation, and corrective and preventive action (CAPA).
  • Design Controls and Product Development: Insights into documented deficiencies involving design changes, verification, validation, risk assessments, and product development records.
  • Supplier and Production Controls: Review of purchasing controls, supplier qualification, manufacturing procedures, monitoring equipment, and nonconforming product management.
  • FDA Warning Letter Intelligence: Listings of medical device manufacturers receiving FDA warning letters, supporting regulatory surveillance and competitive compliance benchmarking.
  • Regulatory References: Medical Device Reporting requirements under 21 CFR Part 803 and references to the Medical Device Single Audit Program (MDSAP).

Why This Intelligence Matters

For Medical Device Quality Assurance Directors, Regulatory Affairs Professionals, Compliance Officers, Supplier Quality Engineers, R&D Leaders, and Manufacturing Executives, understanding FDA enforcement patterns supports more informed compliance decisions.

Identifying recurring quality system deficiencies can help organizations evaluate internal procedures, prioritize compliance audits, strengthen supplier oversight, and prepare for FDA inspections.

Turn FDA Enforcement Intelligence Into Action

Purchase ComplyFDA’s Medical Device FDA Insider Intelligence Quarterly Report to access regulatory citation analysis, warning letter intelligence, and documented quality system deficiencies affecting medical device manufacturers.

Make informed, risk-based decisions to strengthen your organization’s FDA compliance and inspection readiness.

Go to Top